Indian biotech sector growth slows

31 August 2008

The Indian biotechnology sector achieved revenue of $2.5 billion in the 2007-08 fiscal year, a rise of 20% over the same year-earlier period. However, the sector trade body, the Association of Biotechnology-Led Enterprises said that growth was lower than the 30% recorded over the previous five years. The biopharmaceutical segment of the industry also had relatively slow growth - about 16% - in the reporting year though it accounted for two-thirds of the biotechnology sector's total revenue. The ABLE said the biopharmaceutical industry is expected to put on good growth over the next five years.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight